Comparative single- and multiple-dose pharmacokinetics of levodopa and 3-O-methyldopa following a new dual-release and a conventional slow-release formulation of levodopa and benserazide in healthy subjects

By Gasser U.E.   Crevoisier C.   Ouwerkerk M.   Lankhaar G.   Dingemanse J.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 46, Iss. 2, 1998-09 ,pp. : 223-228

Elsevier

Access to resources Recommend Favorite

Food Does Not Influence the Pharmacokinetics of a New Extended Release Formulation of Tolterodine for Once Daily Treatment of Patients with Overactive Bladder

By Olsson B.  

Clinical Pharmacokinetics, Vol. 40, Iss. 2, 2001-01 ,pp. : 135-143

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of a Novel Anagrelide Extended‐Release Formulation in Healthy Subjects: Food Intake and Comparison With a Reference Product

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 2, 2018-02 ,pp. : 123-131

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO‐02, an extended release formulation of oxycodone with sequestered naltrexone

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 5, 2015-09 ,pp. : 370-376

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO‐02, an extended release formulation of oxycodone with sequestered naltrexone

By  

Clinical Pharmacology In Drug Development, Vol. 2160-763X, Iss. 5, 2015-09 ,pp. : 370-376

John Wiley & Sons Inc

Access to resources Recommend Favorite